Russian Ministry will establish new bio-targets for drug analogues developing

| By | Drug Development, Innovative Medicines

The Ministry of Industry and Trade of Russia will make changes to the List of bio-targets for developing the analogs of innovative medicinal products that are similar and improved in terms of their pharmacotherapeutic effect.

The need to amend the document is associated with the increased opportunities for the Russian organizations developing narcotic and immunobiological medicinal products to receive subsidies from the federal budget. At this point, the list of bio-targets includes 96 items.

The draft regulatory legal act is expected to come into force in April 2017.